Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$42.05 - $47.77 $22,454 - $25,509
-534 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$40.23 - $47.74 $643 - $763
-16 Reduced 2.91%
534 $23,000
Q2 2021

Aug 23, 2021

BUY
$36.52 - $41.46 $12,782 - $14,511
350 Added 175.0%
550 $23,000
Q1 2021

Apr 28, 2021

SELL
$34.27 - $40.01 $7,128 - $8,322
-208 Reduced 50.98%
200 $7,000
Q4 2020

Feb 25, 2021

SELL
$34.07 - $39.94 $238 - $279
-7 Reduced 1.69%
408 $15,000
Q3 2020

Nov 30, 2020

BUY
$38.11 - $42.99 $3,696 - $4,170
97 Added 30.5%
415 $15,000
Q1 2020

May 08, 2020

BUY
$32.47 - $48.83 $5,682 - $8,545
175 Added 122.38%
318 $13,000
Q4 2019

Feb 14, 2020

BUY
$42.0 - $48.25 $6,006 - $6,899
143 New
143 $7,000
Q2 2019

Aug 27, 2019

SELL
$39.4 - $42.7 $2,364 - $2,562
-60 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$39.75 - $42.69 $7,791 - $8,367
-196 Reduced 76.56%
60 $2,000
Q2 2018

Jul 31, 2018

SELL
$39.61 - $42.76 $79 - $85
-2 Reduced 0.78%
256 $11,000
Q1 2018

May 21, 2018

SELL
$36.18 - $40.15 $108 - $120
-3 Reduced 1.15%
258 $10,000
Q4 2017

Feb 01, 2018

BUY
$35.34 - $41.9 $9,223 - $10,935
261
261 $9,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $68.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.